Abstract
For several decades, it has been known that T-cell activation in vitro leads to increased glycolytic metabolism that fuels proliferation and effector function. Recently, this simple model has been complicated by the observation that different T-cell subsets differentially regulate fundamental metabolic pathways under the control of distinct molecular regulators. Although the majority of these data have been generated in vitro, several recent studies have documented the metabolism of T cells activated in vivo. Here, we review the recent data surrounding the differential regulation of metabolism by distinct T-cell subsets in vitro and in vivo and discuss how differential metabolic regulation might facilitate T-cell function vis-à-vis proliferation, survival, and energy production. We further discuss the important therapeutic implications of differential metabolism across T-cell subsets and review recent successes in exploiting lymphocyte metabolism to treat immune-mediated diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 104-115 |
Number of pages | 12 |
Journal | Immunological Reviews |
Volume | 249 |
Issue number | 1 |
DOIs | |
State | Published - Sep 2012 |
Externally published | Yes |
Keywords
- Bz-423
- glycolysis
- lymphocyte
- metabolism
- oxidative phosphorylation
- reactive oxygen species